Sandbox Reserved 1177

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (03:55, 21 April 2016) (edit) (undo)
 
Line 4: Line 4:
==Introduction==
==Introduction==
[[Image:surfaceprotein.png |300 px|below|thumb|'''Figure 1'''.Top view of NTSR1 protein interacting with NTS ligand]]
[[Image:surfaceprotein.png |300 px|below|thumb|'''Figure 1'''.Top view of NTSR1 protein interacting with NTS ligand]]
-
Neurotensin receptor 1 (NTSR1) is a '''[https://en.wikipedia.org/wiki/G_protein%E2%80%93coupled_receptor G-protein coupled receptor (GPCR).]''' GPCRs are a class of proteins with an extracellular binding domain and 7 transmembrane helices found only in '''[https://en.wikipedia.org/wiki/Eukaryote. eukaryotes]''' that assist in propagating a cellular response. This is accomplished by the binding of molecules to the GPCR outside the cell,causing a conformational change and activating a signal transduction pathway via '''[https://en.wikipedia.org/wiki/Second_messenger_system second messengers]''' such as '''[https://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate. cyclic AMP]''', '''[https://en.wikipedia.org/wiki/Inositol_trisphosphate. inositol triphosphate]''', and '''[https://en.wikipedia.org/wiki/Diglyceride . diacylglycerol]'''.<ref name="SPGP"/>. NTSR1 binds to the 13 amino acid peptide, neurotensin (NTS)<ref name="SONT">PMID:23051748</ref>, and the majority of the effects of NTS are mediated through NTSR1<ref name="SONT"/>. NTS has a variety of biological activities including a role in the leptin signalling pathways <ref name="Mice">PMID: 20211191</ref>, tumor growth <ref name="cancer">PMID:16887236</ref>, and dopamine regulation <ref name="Schizophrenia">PMID:22596253</ref>.Recently NTSR1 was crystallized bound with the C-terminus of its tridecapeptide ligand, <scene name='72/721548/Neurotensin/7'>NTS(8-13)</scene>. The shortened ligand was used because it has a higher potency and efficacy than its full-length counterpart<ref name="SONT"/>. Class A GPCRs bind their ligands within the transmembrane core in a ligand binding pocket. The <scene name='72/721547/Hydrophobic_binding_pocket/5'>ligand binding pocket</scene> in NTSR1 is located at the top of the protein (Figure 1). NTSR1 also contains an '''[https://en.wikipedia.org/wiki/Allosteric_regulation allosteric]''' <scene name='72/721548/Na_bind_pocket/13'>Na Binding Pocket</scene>. The Na+ binding pocket is located directly beneath the ligand binding pocket and the two pockets are separated by the residue W321. <ref name="SPGP">PMID:26205105</ref>. NTSR1 has been mutated to exist in both <scene name='72/721548/Ntsr1-elf/3'>active</scene>and <scene name='72/721547/Ntsr1-gw5/6'>active-like</scene> states. This has led to a greater understanding of the structure of NTSR1 and how the structure influences its function.
+
Neurotensin receptor 1 (NTSR1) is a '''[https://en.wikipedia.org/wiki/G_protein%E2%80%93coupled_receptor G-protein coupled receptor (GPCR).]''' GPCRs are a class of proteins with an extracellular binding domain and 7 transmembrane helices found only in '''[https://en.wikipedia.org/wiki/Eukaryote. eukaryotes]''' that assist in propagating a cellular response. This is accomplished by the binding of molecules to the GPCR outside the cell,causing a conformational change and activating a signal transduction pathway via '''[https://en.wikipedia.org/wiki/Second_messenger_system second messengers]''' such as '''[https://en.wikipedia.org/wiki/Cyclic_adenosine_monophosphate. cyclic AMP]''', '''[https://en.wikipedia.org/wiki/Inositol_trisphosphate. inositol triphosphate]''', and '''[https://en.wikipedia.org/wiki/Diglyceride . diacylglycerol]'''.<ref name="SPGP"/>. NTSR1 binds to the 13 amino acid peptide, neurotensin (NTS)<ref name="SONT">PMID:23051748</ref>, and the majority of the effects of NTS are mediated through NTSR1<ref name="SONT"/>. NTS has a variety of biological activities including a role in the leptin signalling pathways <ref name="Mice">PMID: 20211191</ref>, tumor growth <ref name="cancer">PMID:16887236</ref>, and dopamine regulation <ref name="Schizophrenia">PMID:22596253</ref>.Recently NTSR1 was crystallized bound with the C-terminus of its tridecapeptide ligand, <scene name='72/721548/Neurotensin/7'>NTS(8-13)</scene>. The shortened ligand was used because it has a higher potency and efficacy than its full-length counterpart<ref name="SONT"/>. Class A GPCRs bind their ligands within the transmembrane core in a ligand binding pocket. The <scene name='72/721547/Hydrophobic_binding_pocket/5'>ligand binding pocket</scene> in NTSR1 is located at the top of the protein (Figure 1). NTSR1 also contains an '''[https://en.wikipedia.org/wiki/Allosteric_regulation allosteric]''' <scene name='72/721548/Na_bind_pocket/13'>Na Binding Pocket</scene>. The Na+ binding pocket is located directly beneath the ligand binding pocket and the two pockets are separated by the residue W321. <ref name="SPGP">PMID:26205105</ref>. NTSR1 has been mutated to exist in both <scene name='72/721548/Ntsr1-elf/6'>active</scene>and <scene name='72/721547/Ntsr1-gw5/8'>active-like</scene> states. This has led to a greater understanding of the structure of NTSR1 and how the structure influences its function.
== Structure ==
== Structure ==

Current revision

An interactive view of the class A GPCR, NTSR1 (blue). This protein gets its activity from binding to the 13 amino acid ligand, NTS (red).

Drag the structure with the mouse to rotate

References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 Krumm BE, White JF, Shah P, Grisshammer R. Structural prerequisites for G-protein activation by the neurotensin receptor. Nat Commun. 2015 Jul 24;6:7895. doi: 10.1038/ncomms8895. PMID:26205105 doi:http://dx.doi.org/10.1038/ncomms8895
  2. 2.0 2.1 2.2 2.3 2.4 2.5 White JF, Noinaj N, Shibata Y, Love J, Kloss B, Xu F, Gvozdenovic-Jeremic J, Shah P, Shiloach J, Tate CG, Grisshammer R. Structure of the agonist-bound neurotensin receptor. Nature. 2012 Oct 25;490(7421):508-13. doi: 10.1038/nature11558. Epub 2012 Oct 10. PMID:23051748 doi:http://dx.doi.org/10.1038/nature11558
  3. 3.0 3.1 3.2 3.3 Liang Y, Boules M, Li Z, Williams K, Miura T, Oliveros A, Richelson E. Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice. Neuropharmacology. 2010 Jun;58(8):1199-205. doi:, 10.1016/j.neuropharm.2010.02.015. Epub 2010 Mar 6. PMID:20211191 doi:http://dx.doi.org/10.1016/j.neuropharm.2010.02.015
  4. 4.0 4.1 4.2 Carraway RE, Plona AM. Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools. Peptides. 2006 Oct;27(10):2445-60. Epub 2006 Aug 2. PMID:16887236 doi:http://dx.doi.org/10.1016/j.peptides.2006.04.030
  5. 5.0 5.1 5.2 Griebel G, Holsboer F. Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov. 2012 May 18;11(6):462-78. doi: 10.1038/nrd3702. PMID:22596253 doi:http://dx.doi.org/10.1038/nrd3702
Personal tools